[Argyria cutis following colloidal silver treatment in two patients with in situ melanoma].

IF 0.8 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL
Marcell Dömötör, Judit Csősz, Lajos Kocsis, Iván Oroján
{"title":"[Argyria cutis following colloidal silver treatment in two patients with in situ melanoma].","authors":"Marcell Dömötör, Judit Csősz, Lajos Kocsis, Iván Oroján","doi":"10.1556/650.2025.33257","DOIUrl":null,"url":null,"abstract":"<p><p>Prior to the discovery and popularization of antibiotics, silver colloidal derivatives were widely used, mainly for the treatment of infections, due to their possible antibacterial and antiviral activity. The silver colloid solution contains microscopic silver particles suspended in a colloidal base. Although there are no clinical trials or reliable literature to prove its efficacy, the increasing interest in alternative and natural remedies has been accompanied by a parallel increase in the indication of silver colloid use for the treatment of various pathologies and for preventive purposes. In the following case reports, the authors detail the case of two male patients who developed in situ neoplastic skin lesions and consumed a daily silver colloid solution on the advice of a naturopath for malignancy prevention. The skin lesions showed no change but argyria has occurred in the skin and nailbed. The aim of this case report is to draw attention to the potential toxicity of silver colloid. The assessment of effectiveness of this therapy is not possible because the in situ neoplastic lesions (lentigo maligna melanoma and superficial spreading melanoma) without any treatment may stay in a preinvasive stage for decades. Orv Hetil. 2025; 166(13): 511–515.</p>","PeriodicalId":19911,"journal":{"name":"Orvosi hetilap","volume":"166 13","pages":"511-515"},"PeriodicalIF":0.8000,"publicationDate":"2025-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Orvosi hetilap","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1556/650.2025.33257","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Prior to the discovery and popularization of antibiotics, silver colloidal derivatives were widely used, mainly for the treatment of infections, due to their possible antibacterial and antiviral activity. The silver colloid solution contains microscopic silver particles suspended in a colloidal base. Although there are no clinical trials or reliable literature to prove its efficacy, the increasing interest in alternative and natural remedies has been accompanied by a parallel increase in the indication of silver colloid use for the treatment of various pathologies and for preventive purposes. In the following case reports, the authors detail the case of two male patients who developed in situ neoplastic skin lesions and consumed a daily silver colloid solution on the advice of a naturopath for malignancy prevention. The skin lesions showed no change but argyria has occurred in the skin and nailbed. The aim of this case report is to draw attention to the potential toxicity of silver colloid. The assessment of effectiveness of this therapy is not possible because the in situ neoplastic lesions (lentigo maligna melanoma and superficial spreading melanoma) without any treatment may stay in a preinvasive stage for decades. Orv Hetil. 2025; 166(13): 511–515.

[2例原位黑色素瘤患者胶体银治疗后皮肤银中毒]。
在抗生素的发现和普及之前,银胶体衍生物由于其可能的抗菌和抗病毒活性而被广泛应用,主要用于治疗感染。银胶体溶液包含悬浮在胶体基中的微小银颗粒。虽然没有临床试验或可靠的文献来证明其疗效,但对替代疗法和自然疗法的兴趣日益增加,同时也伴随着银胶体用于治疗各种病理和预防目的的适应症的增加。在以下病例报告中,作者详细介绍了两名男性患者的病例,他们发展为原位肿瘤性皮肤病变,并根据自然疗法预防恶性肿瘤的建议,每天服用银胶体溶液。皮肤病变未见改变,但皮肤及指甲出现银质。本病例报告的目的是提请注意银胶体的潜在毒性。由于原位肿瘤病变(色素体恶性黑色素瘤和浅表性扩散黑色素瘤)未经任何治疗可能会停留在侵袭前阶段数十年,因此无法评估该疗法的有效性。Orv Hetil. 2025;166(13): 511 - 515。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Orvosi hetilap
Orvosi hetilap MEDICINE, GENERAL & INTERNAL-
CiteScore
1.20
自引率
50.00%
发文量
274
期刊介绍: The journal publishes original and review papers in the fields of experimental and clinical medicine. It covers epidemiology, diagnostics, therapy and the prevention of human diseases as well as papers of medical history. Orvosi Hetilap is the oldest, still in-print, Hungarian publication and also the one-and-only weekly published scientific journal in Hungary. The strategy of the journal is based on the Curatorium of the Lajos Markusovszky Foundation and on the National and International Editorial Board. The 150 year-old journal is part of the Hungarian Cultural Heritage.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信